ChromaDex Corp. Files Q2 2024 10-Q

TL;DR

ChromaDex Q2 2024 10-Q filed. Financials updated.

AI Summary

ChromaDex Corp. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company's fiscal year ends on December 31st. Key financial data and business operations for the second quarter of 2024 are detailed in this filing.

Why It Matters

This filing provides investors with an update on ChromaDex's financial health and operational status for the second quarter of 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a 10-Q filing, it contains detailed financial information that could reveal risks or opportunities, but it's a standard disclosure for public companies.

Key Numbers

• 20240630 — End of Reporting Period (This date marks the end of the financial quarter being reported.)
• 20240807 — Filing Date (This is the date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

• ChromaDex Corp. (company) — Filer of the 10-Q
• 20240630 (date) — End of the reporting period
• 20240807 (date) — Filing date
• LOS ANGELES (location) — Company's business and mailing address city
• DE (location) — State of incorporation

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value per share CDXC The Nasdaq Cap

Filing Documents

• cdcx-20240630.htm (10-Q) — 1411KB
• cdxcex-311q22024.htm (EX-31.1) — 10KB
• cdxcex-312q22024.htm (EX-31.2) — 10KB
• cdxcex-321q22024.htm (EX-32.1) — 6KB
• cdcx-20240630_g1.jpg (GRAPHIC) — 26KB
• 0001628280-24-035591.txt ( ) — 6926KB
• cdcx-20240630.xsd (EX-101.SCH) — 42KB
• cdcx-20240630_cal.xml (EX-101.CAL) — 50KB
• cdcx-20240630_def.xml (EX-101.DEF) — 202KB
• cdcx-20240630_lab.xml (EX-101.LAB) — 540KB
• cdcx-20240630_pre.xml (EX-101.PRE) — 367KB
• cdcx-20240630_htm.xml (XML) — 1152KB

- Financial Information (unaudited)

PART I - Financial Information (unaudited) Pg.

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited): 3 Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 3 Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and June 30, 2023 4 Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended June 30, 2024 and June 30, 2023 5 Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and June 30, 2023 7 Notes to Condensed Consolidated Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 27

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 34

Controls and Procedures

Item 4. Controls and Procedures 34

- Other Information

PART II - Other Information

Legal Proceedings

Item 1. Legal Proceedings 34

Risk Factors

Item 1A. Risk Factors 36

Other information

Item 5. Other information 58

Exhibits

Item 6. Exhibits 59

Signatures

Signatures 60 2 Table of Contents PART I

FINANCIAL STATEMENTS (unaudited)

Item 1. FINANCIAL STATEMENTS (unaudited) ChromaDex Corporation and Subsidiaries Unaudited Condensed Consolidated Balance Sheets (In thousands except par values, unless otherwise indicated) June 30, 2024 December 31, 2023 Assets Current assets Cash and cash equivalents, including restricted cash of $ 152 for both periods presented $ 27,885 $ 27,325 Trade receivables, net of allowances of $ 85 and $ 68 , respectively; Including receivables from Related Party of $ 3.5 million and $ 2.8 million, respectively 7,818 5,234 Inventories 11,511 14,525 Prepaid expenses and other assets 2,088 2,450 Total current assets 49,302 49,534 Leasehold improvements and equipment, net 1,841 2,137 Intangible assets, net 435 510 Right-of-use assets, net 2,063 2,400 Other long-term assets 394 383 Total assets $ 54,035 $ 54,964 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 8,105 $ 10,232 Accrued expenses 8,621 9,493 Current maturities of operating lease obligations 973 691 Current maturities of finance lease obligations 12 11 Customer deposits 156 195 Total current liabilities 17,867 20,622 Deferred revenue 3,311 3,311 Operating lease obligations, less current maturities 2,133 2,563 Finance lease obligations, less current maturities 6 12 Total liabilities 23,317 26,508 Commitments and Contingencies (Note 10) Stockholders' Equity Common stock, $ 0.001 par value; authorized 150,000 shares; 75,473 shares and 74,981 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 75 75 Additional paid-in capital 221,612 218,845 Accumulated deficit ( 190,967 ) ( 190,460 ) Cumulative translation adjustments ( 2 ) ( 4 ) Total stockholders' equity 30,718 28,456 Total liabilities and stockholders' equity $ 54,035 $ 54,964 See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements. 3 Table of Contents ChromaDex Corporation and Subsidiaries Unaudited Condensed Consolidated Statem

View Full Filing

View this 10-Q filing on SEC EDGAR